Novartis Corporation in Talks to Buy Much of Elan Corporation PLC

Bookmark and Share

Reuters -- Swiss drugmaker Novartis is in talks to buy parts of Irish peer Elan, including its flagship multiple sclerosis products and its Alzheimer’s disease pipeline, the Sunday Times said.

MORE ON THIS TOPIC